Drawing for MIMIVAX

USPTO serial 86771918

MIMIVAX

Reviewed by CopyMark Law Group

Reg. 5775811Status 702Registered
Filing date
Status date
Registration date
Jun 11, 2019
Examiner
RIRIE, VERNA BETH
Law office
Historical data usage

What this means

Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use. Continue use in commerce and plan for the 10-year Section 8 and 9 renewal.

Status 702: Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use.

Need help with MIMIVAX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Michael E. Storck

Michael E. Storck Lippes Mathias Wexler Friedman LLP50 Fountain Plaza, Suite 1700Buffalo, NY 14202United States

Goods and services

ClassDescriptionStatusFirst use
042Research and development of pharmaceuticals for the prevention and treatment of cancerACTIVEAug 22, 2011

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Feb 24, 2025NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Feb 24, 2025C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Feb 24, 2025APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Oct 17, 2024E815TEAS SECTION 8 & 15 RECEIVED—
Jun 11, 2024REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Jun 11, 2019R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 7, 2019SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
May 6, 2019CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Apr 17, 2019SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Apr 15, 2019IUAFUSE AMENDMENT FILED—
Apr 15, 2019EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Nov 6, 2018EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 5, 2018EX5GSOU EXTENSION 5 GRANTED—
Nov 5, 2018AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Oct 26, 2018EXT5SOU EXTENSION 5 FILED—
Oct 26, 2018EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 14, 2018EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Apr 12, 2018EX4GSOU EXTENSION 4 GRANTED—
Apr 12, 2018EXT4SOU EXTENSION 4 FILED—
Apr 12, 2018EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 12, 2017EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Oct 10, 2017EX3GSOU EXTENSION 3 GRANTED—
Oct 10, 2017EXT3SOU EXTENSION 3 FILED—
Oct 10, 2017EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 12, 2017EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Apr 10, 2017EX2GSOU EXTENSION 2 GRANTED—
Apr 10, 2017EXT2SOU EXTENSION 2 FILED—
Apr 10, 2017EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 5, 2016EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 3, 2016EX1GSOU EXTENSION 1 GRANTED—
Nov 3, 2016EXT1SOU EXTENSION 1 FILED—
Nov 3, 2016EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 25, 2016TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
May 3, 2016NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Mar 8, 2016NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 8, 2016PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 17, 2016NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jan 25, 2016CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 19, 2016DOCKASSIGNED TO EXAMINER—
Oct 5, 2015NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 2, 2015NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance